Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants

被引：0
|
作者：
Vidya Perera
Grigor Abelian
Danshi Li
Zhaoqing Wang
Liping Zhang
Susan Lubin
Wei Chen
Akintunde Bello
Bindu Murthy
机构：
[1] Early Clinical and Translational Research,Global Clinical Pharmacology
[2] Bristol Myers Squibb,undefined
[3] Janssen Research & Development,undefined
[4] LLC,undefined
来源：
Clinical Pharmacokinetics | 2022年 / 61卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：857 / 867
页数：10
相关论文
共 50 条
  • [1] Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants
    Perera, Vidya
    Abelian, Grigor
    Li, Danshi
    Wang, Zhaoqing
    Zhang, Liping
    Lubin, Susan
    Chen, Wei
    Bello, Akintunde
    Murthy, Bindu
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (06) : 857 - 867
  • [2] Single-dose pharmacokinetics of BMS-986177/JNJ-70033093 in participants with mild or moderate hepatic impairment compared to healthy participants
    Perera, V
    Abelian, G.
    Li, D.
    Wang, Z.
    Zhang, L.
    Lubin, S.
    Wang, J.
    Bello, A.
    Murthy, B.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 3371 - 3371
  • [3] Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment
    Perera, Vidya
    Abelian, Grigor
    Li, Danshi
    Wang, Zhaoqing
    Zhang, Liping
    Lubin, Susan
    Bello, Akintunde
    Murthy, Bindu
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (10) : 1405 - 1416
  • [4] Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment
    Vidya Perera
    Grigor Abelian
    Danshi Li
    Zhaoqing Wang
    Liping Zhang
    Susan Lubin
    Akintunde Bello
    Bindu Murthy
    [J]. Clinical Pharmacokinetics, 2022, 61 : 1405 - 1416
  • [5] Pharmacokinetics and Safety of Single-dose Atogepant in Participants with Hepatic Impairment
    Boinpally, R.
    Jakate, A.
    Butler, M.
    Borbridge, L.
    Periclou, A.
    [J]. HEADACHE, 2020, 60 : 45 - 46
  • [6] Pharmacokinetics, Safety, and Tolerability of Single-Dose Elbasvir in Participants with Hepatic Impairment
    Marshall, William L.
    Feng, Hwa-Ping
    Wenning, Larissa
    Garrett, Graigory
    Huang, Xiaobi
    Liu, Fang
    Panebianco, Deborah
    Caro, Luzelena
    Fandozzi, Christine
    Lasseter, Kenneth C.
    Preston, Richard A.
    Marbury, Thomas
    Butterton, Joan R.
    Iwamoto, Marian
    Yeh, Wendy W.
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (03) : 321 - 329
  • [7] Pharmacokinetics, Safety, and Tolerability of Single-Dose Elbasvir in Participants with Hepatic Impairment
    William L. Marshall
    Hwa-Ping Feng
    Larissa Wenning
    Graigory Garrett
    Xiaobi Huang
    Fang Liu
    Deborah Panebianco
    Luzelena Caro
    Christine Fandozzi
    Kenneth C. Lasseter
    Richard A. Preston
    Thomas Marbury
    Joan R. Butterton
    Marian Iwamoto
    Wendy W. Yeh
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 321 - 329
  • [8] Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Oral Ivosidenib in Otherwise Healthy Participants
    Fan, Bin
    Dai, David
    Cohen, Marvin
    Xu, Huansheng
    Yin, Feng
    Nagaraja, Raj
    Mobilia, Michelle
    Almon, Caroline
    Basile, Frank G.
    Yang, Hua
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (01): : 99 - 109
  • [9] Single-dose Pharmacokinetics of Eluxadoline in Healthy Participants With Normal Renal Function and Participants With Renal Impairment
    Boinpally, Ramesh
    Weissman, Darren
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (02): : 132 - 140
  • [10] SINGLE-DOSE SAFETY AND PHARMACOKINETICS OF APIXABAN IN SUBJECTS WITH MILD OR MODERATE HEPATIC IMPAIRMENT
    Frost, C. E.
    Yu, Z.
    Wang, J.
    Li, T.
    Zeigler, C.
    Schuster, A.
    Ly, V.
    Zhang, D.
    LaCreta, F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S34 - S34
12345